Meeting
2023 ASCO Genitourinary Cancers Symposium
Impact of chemotherapy on anxiety, depression, and suicidality amongst testicular cancer survivors.
Authors
Tyler J. Nelson
VA San Diego Health Care System, La Jolla, CA
Tyler J. Nelson , Margaret F Meagher , Austin Leonard , Isabella Dolendo , Leah N. Deshler , Kylie M. Morgan , Elizabeth A. Duran , Daniel Sabater Minarim , Luke Wang , Jacob Taylor , Daniel Herchenhorn , Tyler F. Stewart , Juan Javier-Desloges , Amir Salmasi , Rana R. McKay , Fred Millard , Brent S Rose , Aditya Bagrodia
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Symptoms, Toxicities, Patient-Reported Outcomes, and Whole-Person Care
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 418)
DOI
10.1200/JCO.2023.41.6_suppl.418
Abstract #
418
Poster Bd #
L20
Abstract Disclosures
Similar Posters
Poster
2017 Cancer Survivorship Symposium
Unmet need, survivorship concerns, and psychosocial outcomes among testicular cancer (TC) survivors.
First Author: Steven C Palmer
Poster
2023 ASCO Annual Meeting
Hospital Anxiety and Depression Scale (HADS) score trends among testicular cancer survivors: A longitudinal study.
First Author: Khalid Y. Alkhatib
Poster
2021 Genitourinary Cancers Symposium
Paternity, relationship, sexual activity and fertility in testicular cancer (TC) survivors (TCS): Results from a single institution observational prospective study.
First Author: Davide Bimbatti
Poster
2018 Cancer Survivorship Symposium
A brief intervention for chemobrain: Results from a pilot study.
First Author: Jennifer Bennett